Back

Effects of colchicine on cardiac structure and function in patients with hypertension: a prespecified secondary analysis of the COlchicine HypERtENsion Trial (COHERENT)

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Hypertension treatment (2) Target Organ Damage/Left Ventricular Hypertrophy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Adam Femerling Langhoff

Herlev and Gentofte Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Six-month renal marker trajectories with azilsartan–indapamide versus azilsartan–nitrendipine in essential hypertension: a pragmatic comparative study
Assistant Professor Z. Mashkurova (Tashkent, UZ)
Abstract
Presentation thumbnail
The effect of eplerenone vs irbesartan as first line therapy in obese hypertensive patients on left ventricular hypertrophy and diastolic dysfunction: echocardiographic results of the HEBRO randomized
Doctor M. Kouremeti (Athens, GR)
Abstract
Presentation thumbnail
Sex specific associations between blood pressure in midlife and left ventricular hypertrophy in older women and men
Doctor E. Kringeland (Bergen, NO)
Abstract
Presentation thumbnail
Perception of self-efficacy improves adherence in hypertensive patients
Associate Professor A. Farcas (Cluj Napoca, RO)
Abstract
Presentation thumbnail
Gender, age and regional disparities in antihypertensive prescribing and medication adherence: evidence from linked survey and claims data
Professor S. Spethmann (Berlin, DE)
Abstract

Access the full session

Session thumbnail
Hypertension treatment (2)

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Low-dose colchicine in patients treated with percutaneous coronary interventions for myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
29 August 2020
thumbnail
Congress Presentation
Abnormal left ventricular and left atrial mechanics in patients with resistant hypertension
13 December 2024
thumbnail
ESC Journals
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial
20 November 2020
thumbnail
Congress Presentation
The beneficial role of cardioprotective drugs in preventing cardiotoxicity in HER2 positive breast cancer, an echocardiographic point-of-view
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources